FDA Seeks Comments on Food Additive Petition Forms
Published Date: 9/29/2026
Notice
Summary
The FDA is asking for public feedback on how it collects info about food and color additives, including their labels and safety petitions. This affects companies that want to add or change ingredients in food and how they submit their paperwork electronically. Comments are due by October 29, 2026, and the process helps keep food safe without adding extra costs or delays.
Analyzed Economic Effects
4 provisions identified: 2 benefits, 2 costs, 0 mixed.
Color add-on petition fees for businesses
If you submit a color additive petition (CAP), you must pay a listing fee that ranges from $1,600 to $3,000 depending on the use and scope. FDA expects an average of four CAPs per year (two Category A and two Category B), and calculates expected annual listing fees of up to $11,200 ((2 × $2,600) + (2 × $3,000)).
Large time burden to prepare petitions
Preparing petitions takes many hours. FDA estimates an average of 7,093 hours per food additive petition (FAP) and 1,337 hours per color additive petition (CAP). FDA totals these as 21,279 hours for FAPs and 5,348 hours for CAPs, with an overall annual estimated burden of 26,632 hours.
Electronic filing via COSM and Form FDA 3503
You can submit FAPs or CAPs electronically using the Centralized Online Submission Module (COSM) and Form FDA 3503. COSM is available 24 hours a day, 7 days a week, supports electronic submissions (so you do not need to print and mail paper submissions), and Form FDA 3503 helps organize submissions and master files.
Labeling rules do not add extra paperwork
FDA says labeling information required under the cited regulations does not require additional information gathering or unique recordkeeping beyond what is already needed for safety reviews. The burden hours for labeling are included in the FAP and CAP burden estimates, and FDA states there are no capital costs associated with this information collection.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-16296, Substances Generally Recognized as Safe
The Food and Drug Administration (FDA or we) is proposing to require the submission of generally recognized as safe (GRAS) notices for the use of a human or animal food substance purported to be GRAS under the conditions of its intended use under the Federal Food, Drug, and Cosmetic Act (FD&C Act).
2026-14073, Drug Establishment Registration and Drug Listing Requirements for Establishments Engaged in Distributed Manufacturing and Certain Foreign Establishments
The FDA wants to make it easier for drug makers who work in several locations to register as one company instead of many. They’re also updating rules for foreign drug companies to match new laws about handling health threats. If you’re in drug manufacturing, get ready to comment by September 11, 2026, and keep an eye on possible paperwork changes that could affect your business.
2026-13047, Establishment Registration and Product Listing for Tobacco Products
The FDA wants to make sure all tobacco product makers, both in the U.S. and abroad, register their businesses and list their products. This new rule closes a big gap by including foreign companies, helping the FDA keep better track of tobacco products for public health. Comments on this proposal are open until September 14, 2026, so affected businesses should get ready to update their info and possibly face new costs.
2025-01840, Nonprescription Drug Product With an Additional Condition for Nonprescription Use
The FDA’s new rule about nonprescription drugs needing extra conditions before use was set to start on January 27, 2025, but it’s now delayed until March 21, 2025. This delay follows a presidential order to pause and review new rules before they take effect. Drug makers, sellers, and consumers should note the new start date and get ready for the updated rules soon.
2026-19921, Determination That SULFADIAZINE (Sulfadiazine) Tablet, 500 Milligrams, Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness
The FDA has decided that the 500 mg sulfadiazine tablet wasn’t taken off the market because it was unsafe or didn’t work. This means generic drug makers can now apply to sell their versions, as long as they meet all the rules. Patients and pharmacies could see more affordable options soon, with no safety worries holding things back.
2026-19849, Agency Information Collection Activities; Proposed Collection; Comment Request; Protection of Human Subjects and Institutional Review Boards
The FDA wants your thoughts on how they collect info about medical devices to keep people safe. This affects anyone involved in medical research or device tracking and aims to improve how data is gathered without adding extra hassle. You’ve got until November 30, 2026, to share your comments, so don’t miss out on shaping the future of health safety!
Previous / Next Documents
Previous: 2026-19849, Agency Information Collection Activities; Proposed Collection; Comment Request; Protection of Human Subjects and Institutional Review Boards
The FDA wants your thoughts on how they collect info about medical devices to keep people safe. This affects anyone involved in medical research or device tracking and aims to improve how data is gathered without adding extra hassle. You’ve got until November 30, 2026, to share your comments, so don’t miss out on shaping the future of health safety!
Next: 2026-19851, Administrative Declaration of a Disaster for the State of NEW YORK
New York got hit by big storms and flooding from July 28-29, 2026, and now the government says it’s an official disaster. People and businesses in certain counties can apply for low-interest loans to fix damage or cover lost income. You’ve got until November 23, 2026, for physical damage loans and June 24, 2027, for economic injury loans—so don’t wait!